FRE DE0005785604

Report

Real-time Estimate Tradegate - 08:53 2022-08-16 am EDT
25.05	EUR		+1.64%

08/15	Moody's Keeps Fresenius' Rating Unchanged Despite Operating Headwinds	MT
08/15	Moody's Confirms Fresenius Medical Care's Stable Outlook Amid Muted Operating Performance	MT
08/09	Chugai Pharmaceutical Co., Ltd. - Notice of the Settlement of Patent Infringement Litigation in the U.S.	AQ

Most relevant news about FRESENIUS SE & CO. KGAA

08/15	Moody's Keeps Fresenius' Rating Unchanged Despite Operating Headwinds	MT
08/08	FRESENIUS : Kabi introduces 2D barcodes in the US	PU
08/05	FRESENIUS SE : Credit Suisse reaffirms its Neutral rating	MD
08/05	FRESENIUS SE : Barclays maintains a Buy rating	MD
08/05	FRESENIUS SE : Warburg Research remains its Buy rating	MD
08/05	FRESENIUS SE & CO. KGAA : Notification and public disclosure of transactions by persons	EQ
08/05	FRESENIUS SE & CO. KGAA : Notification and public disclosure of transactions by persons	EQ
08/05	FRESENIUS SE : Deutsche Bank reiterates its Neutral rating	MD
08/04	FRESENIUS : Factsheet H1/22 (PDF)	PU
08/04	FRESENIUS SE & CO. KGAA : Half-year report	CO
08/02	Fresenius SE & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months ..	CI
08/02	FRESENIUS : Q2/2022 Key Figures (XLSX)	PU
08/02	FRESENIUS : publishes financial results for the second quarter and first half of 2022 in l..	PU
08/02	FRESENIUS : publishes financial results for the second quarter and first half of 2022 in l..	PU
08/02	FRESENIUS : Medical Care publishes financial results for the second quarter and first half..	PU

All news about FRESENIUS SE & CO. KGAA

08/15	Moody's Keeps Fresenius' Rating Unchanged Despite Operating Headwinds	MT
08/15	Moody's Confirms Fresenius Medical Care's Stable Outlook Amid Muted Operating Performan..	MT
08/09	Chugai Pharmaceutical Co., Ltd. - Notice of the Settlement of Patent Infringement Litig..	AQ
08/08	FRESENIUS : Kabi introduces 2D barcodes in the US	PU
08/05	FRESENIUS SE : Credit Suisse reaffirms its Neutral rating	MD
08/05	FRESENIUS SE : Barclays maintains a Buy rating	MD
08/05	FRESENIUS SE : Warburg Research remains its Buy rating	MD
08/05	FRESENIUS SE & CO. KGAA : Notification and public disclosure of transactions by persons	EQ
08/05	FRESENIUS SE & CO. KGAA : Notification and public disclosure of transactions by persons	EQ
08/05	FRESENIUS SE : Deutsche Bank reiterates its Neutral rating	MD

News in other languages on FRESENIUS SE & CO. KGAA

08/15	Moody's maintient la note de Fresenius inchangée malgré des vents contraires d'exploita..
08/15	Moody's confirme la perspective stable de Fresenius Medical Care en dépit d'une perform..
08/15	MÄRKTE EUROPA/Aktien bauen Gewinne aus - Ölpreise stürzen ab
08/15	Moody's bestätigt Bonität von Fresenius Medical Care
08/15	MÄRKTE EUROPA/Gewinne verteidigt - Ölpreise stürzen ab
08/15	MÄRKTE EUROPA/Gewinne verteidigt - Höhepunkt des Sommerlochs
08/12	AKTIEN FRANKFURT ERÖFFNUNG : Starker Wochenausklang in Sicht
08/12	Petit manque d'énergie sur le marché
08/12	AVIS D'ANALYSTES DU JOUR : Sanofi, Sodexo, Eutelsat, TF1, Equinor, Alcon, Dufry, Aegon, Ve..
08/05	FRESENIUS : Quartalsfinanzbericht Q2/22 (PDF)

Analyst Recommendations on FRESENIUS SE & CO. KGAA

08/05	FRESENIUS SE : Credit Suisse reaffirms its Neutral rating	MD
08/05	FRESENIUS SE : Barclays maintains a Buy rating	MD
08/05	FRESENIUS SE : Warburg Research remains its Buy rating	MD
08/05	FRESENIUS SE : Deutsche Bank reiterates its Neutral rating	MD
07/29	FRESENIUS SE : Deutsche Bank reiterates its Neutral rating	MD

Press releases

08/09	Chugai Pharmaceutical Co., Ltd. - Notice of the Settlement of Patent Infringement Litig..	AQ
08/08	FRESENIUS : Kabi introduces 2D barcodes in the US	PU
08/05	FRESENIUS SE & CO. KGAA : Notification and public disclosure of transactions by persons	EQ
08/05	FRESENIUS SE & CO. KGAA : Notification and public disclosure of transactions by persons	EQ
08/04	FRESENIUS : Factsheet H1/22 (PDF)	PU

Analysis